GlassScriptPhysician profile
Allan D Lamb
NPI 1619946894
$19,102.51
in general payments reported to CMS, 2019-2025
34 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $421 · 2021: $323 · 2022: $13K · 2023: $2,211 · 2024: $2,040 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470 · Travel and Lodging: $1,888 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,470.20 |
| Travel and Lodging | $1,887.86 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,835.07 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $559.48 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Csl Behring | $558.46 | 2019-2024 | Kcentra |
| Cerus Corporation | $354.64 | 2023 | Intercept Blood System For Platelets |
| Davol INC. | $195.38 | 2019-2023 | Phasix Mesh |
| Portola Pharmaceuticals, LLC | $178.72 | 2019-2020 | |
| Depuy Synthes Sales INC. | $114.47 | 2022 | |
| Organogenesis INC. | $105.96 | 2021-2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $104.68 | 2020-2024 | Integra, Surgimend, Omnigraft |
| Allergan, INC. | $95.66 | 2019 | |
| W. L. Gore & Associates, INC. | $87.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| My01 INC. | $79.58 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Lemaitre Vascular, INC. | $76.70 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $75.82 | 2023-2025 | Exparel |
| Janssen Pharmaceuticals, INC | $74.95 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $70.09 | 2020 | |
| Kls-Martin L.P. | $58.84 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $50.68 | 2022-2024 | Andexxa |
| Conmed Corporation | $47.59 | 2023 | Airseal |
| Smith+Nephew, INC. | $42.26 | 2019 | |
| Braintree Laboratories, INC. | $34.53 | 2023 | Sutab, Suflave |
| Kerecis Limited | $32.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $31.00 | 2019-2022 | |
| Teleflex LLC | $26.29 | 2023 | Quikclot |
| Heron Therapeutics, INC. | $24.79 | 2022 | |
| Endologix LLC | $23.60 | 2019 | |
| Olympus America INC. | $22.52 | 2024 | Olympus |
| Polarityte, INC. | $22.50 | 2019 | |
| Covidien LP | $21.29 | 2019 | |
| Ge Healthcare | $21.07 | 2023 | |
| Alexion Pharmaceuticals, INC. | $20.50 | 2021 | |
| Becton, Dickinson and Company | $20.47 | 2019 | |
| Medtronic, INC. | $19.85 | 2025 | Transorb |
| Cook Medical LLC | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.